Clinical effect of subthalamic nucleus deep brain stimulation in the adjunctive treatment of Parkinson′s disease
YANG Yinghao1 YAO Qianming1▲ CHENG Guoxiong1 XU Zhenqiu1 TAN Hongyu2
1.Department of Neurosurgery, the First Affiliated Hospital of Guangzhou Medical University, Guangdong Province, Guangzhou 510000, China;
2.Department of Neurology, the First Affiliated Hospital of Guangzhou Medical University, Guangdong Province, Guangzhou 510000, China
Abstract：Objective To study the clinical effect of subthalamic nucleus deep brain stimulation (SNDBS) in the adjunctive treatment of Parkinson′s disease (PD). Methods Ninety-one cases of PD patients treated in the First Affiliated Hospital of Guangzhou Medical University from February 2017 to April 2018 were selected. According to the random number table method, the patients were divided into the observation group（46 cases）and the control group (45 cases). Patients in both groups were treated by conventional therapy such as back percussion and sputum suction, oxygen inhalation and atomization and nutritional support. The control group was given Levodopa and Benserazide Tablets, the observation group was given SNDBS treatment on the basis of the control group. After 3 months of treatment, the curative effect and adverse reactions of the two groups were compared. The unified Parkinson disease rating scale (UPDRS) score, quality of life score, uric acid (UA) and methane dicarboxylic aldehyde (MDA) level were compared between the two groups before and after 3 months of treatment. Results The total effective rate of the observation group was higher than that of the control group (P ＜ 0.05). After treatment, the UPDRS score of the two groups were lower than those before treatment, and the observation group was lower than that of the control group; the quality of life score of the two groups were higher than those before treatment, and the observation group was higher than that of the control group, the differences were statistically significant (P ＜ 0.05); the UA and MDA level of the two groups were lower than those before treatment, and the observation group was lower than that of the control group, the differences were statistically significant (P ＜ 0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion SNDBS is effective in the adjunctive treatment of PD patients. It can improve the symptoms and quality of life of patients, and reduce oxidative stress level.
杨应浩1 姚谦明1▲ 程国雄1 徐振球1 谭红愉2. 丘脑底核脑深部电刺激术辅助治疗帕金森病的临床效果[J]. 中国医药导报, 2019, 16(5): 68-71.
YANG Yinghao1 YAO Qianming1▲ CHENG Guoxiong1 XU Zhenqiu1 TAN Hongyu2. Clinical effect of subthalamic nucleus deep brain stimulation in the adjunctive treatment of Parkinson′s disease. 中国医药导报, 2019, 16(5): 68-71.
2019, Vol. 16 
京公网安备 11010502046598号